oral.glp 1 Oral GLP‑1 Therapy Type 2 Diabetes: A Game-Changer New Trial Shows Oral GLP-1

Findings reported by Borek et al

Simon, A., et al

The pivotal RECONNECT Phase 3 trials, two identically designed randomized, double-blind, placebo-controlled studies involving 1,267 women, established the peptide's therapeutic benefit

Collectively, glutamine-derived metabolites act as epigenetic modulators in a wide range of cell and tissue types, including various types of cancer cells, stem cells, immune cells, and even adipocytes

Improved Cellular Uptake Once in circulation, liposomes merge with cell membranes through a process called fusion , delivering the vitamin C directly into cells where its needed most